# NIRS to Diagnose SAMS

> **NCT03653663** · PHASE4 · UNKNOWN · sponsor: **Hartford Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Statin Adverse Reaction
- Skeletal Myopathy

## Interventions

- **DRUG:** Simvastatin 20 mg
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03653663
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2020-02-29
- **Final completion:** 2020-07-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03653663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03653663, "NIRS to Diagnose SAMS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03653663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*